Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1227585-65-0 | MDL No. : | MFCD16606984 |
Formula : | C6H5BrClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PCMSIEWNWZBDPO-UHFFFAOYSA-N |
M.W : | 222.47 | Pubchem ID : | 71721408 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.07 |
TPSA : | 33.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.51 cm/s |
Log Po/w (iLOGP) : | 1.81 |
Log Po/w (XLOGP3) : | 1.62 |
Log Po/w (WLOGP) : | 1.84 |
Log Po/w (MLOGP) : | 1.25 |
Log Po/w (SILICOS-IT) : | 2.52 |
Consensus Log Po/w : | 1.81 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.62 |
Solubility : | 0.536 mg/ml ; 0.00241 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.93 |
Solubility : | 2.63 mg/ml ; 0.0118 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.33 |
Solubility : | 0.104 mg/ml ; 0.000468 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.84 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | Stage #1: With isopropyl magnesium chloride - lithium chloride complex In tetrahydrofuran at -40 - 20℃; for 1 h; Stage #2: at 20℃; for 0.5 h; Stage #3: With sodium tetrahydroborate In methanol; water at 5℃; for 1 h; |
To a solution of 2,3-dibromo-5-chloropyridine (60 g, 221 mmol) in THF (500 mL) was added a solution of isopropylmagnesium chloride lithium chloride solution in THF (1.3M, 185 mL) at −40° C. over about 30 min. The solution was stirred for 30 min at −40° C. and DMF (50 mL) was added. The resulting solution was warmed up to room temperature and stirred for 30 min. The reaction was quenched with 1 N HCl (400 mL) and MTBE (200 mL) was added. Organic layer was separated and washed twice with 5percent aqueous NaHCO3 (200 mL). The solvent was removed under vacuum at 50° C. The resulting solids (aldehyde intermediate) were dissolved in methanol (400 mL). The solution was cooled to 5° C. under an ice bath. NaBH4 (3.6 g) was added slowly over 30 min while maintaining the reaction temperature below room temperature. The reaction mixture was stirred for another 30 min followed by addition of water (125 mL). The resulting mixture was concentrated under vacuum to approximately 150 ml. Solids precipitated during the concentration. The suspension was stirred vigorously at room temperature for 1 h and solids were collected by filtration. The wet cake was dried in a vacuum oven over night at 60° C. to give 52 (45.6 g, 93percent) as a solid. 1H NMR (CDCl3, 400 MHz): δ 8.26 (d, J=2.5 Hz, 1H), 7.88 (d, J=2.5 Hz, 1H), 4.73 (d, J=5.8 Hz, 2H), 2.33 (t, J=11.4 Hz, 1H); 13C NMR (CDCl3, 100 MHz): δ 147.12, 138.48, 138.39, 136.14, 132.06, 62.76. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | at 5 - 20℃; for 1 h; | To a solution of 2,3-dibromo-5-chloropyridine (60 g, 221 mmol) in THF (500 mL) was added a solution of isopropylmagnesium chloride lithium chloride solution in THF (1.3M, 185 mL) at -40 °C over about 30 min. The solution was stirred for 30 min at -40 °C and DMF (50 mL) was added. The resulting solution was warmed up to room temperature and stirred for 30 min. The reaction was quenched with 1 N HCl (400 mL) and MTBE (200 mL) was added. Organic layer was separated and washed twice with 5percent aqueous NaHC03 (200 mL). The solvent was removed under vacuum at 50 °C. The resulting solids (aldehyde intermediate) were dissolved in methanol (400 mL). The solution was cooled to 5 °C under an ice bath. NaBtit (3.6 g) was added slowly over 30 min while maintaining the reaction temperature below room temperature. The reaction mixture was stirred for another 30 min followed by addition of water (125 mL). The resulting mixture was concentrated under vacuum to approximately 150 ml. Solids precipitated during the concentration. The suspension was stirred vigorously at room temperature for 1 h and solids were collected by filtration. The wet cake was dried in a vacuum oven over night at 60 °C to give 1 (45.6 g, 93percent) as a solid. 1H NMR (CDC13) 400 MHz): <5 8.26 (d, J= 2.5 Hz, 1H), 7.88 (d, J=2.5 Hz, IK), 4.73 (d, J= 5.8 Hz, 2H), 2.33 (t, J= 1 1.4 Hz, 1H); 13C NMR (CDC13, 100 MHz): δ 147.12, 138.48, 138.39, 136.14, 132.06, 62.76. |
45.6 g | at 5 - 20℃; for 1 h; | To a solution of 2,3-dibromo-5-chloropyridine (60 g, 221 mmol) in THF (500 mL) was added a solution of isopropylmagnesium chloride lithium chloride solution in THF (1 .3M, 185 mL) at -40 °C over about 30 mm. The solution was stirred for 30 mm at -40 °C and DMF (50 mL) was added. The resulting solution was warmed up to room temperature and stirred for 30 min. The reaction was quenched with 1 N HCl (400 mL) and MTBE (200 mL) was added. Organic layer was separated and washed twice with 5percent aqueous NaHCO3 (200 mL). The solvent was removed under vacuum at 50 °C. The resulting solids (aldehyde intermediate) were dissolved in methanol (400 mL). The solution was cooled to 5 °C under an ice bath. NaBH4 (3.6 g) was added slowly over 30 min while maintaining the reaction temperature below room temperature. The reaction mixture was stirred for another 30 min followed by addition of water (125 mL). The resulting mixture was concentrated under vacuum to approximately 150 ml. Solids precipitated during the concentration. The suspension was stirred vigorously at room temperature for 1 h and solids were collected by filtration. The wet cake was dried in a vacuum oven over night at 60 °C to give 52 (45.6 g, 93percent) as a solid. 1H NMR (CDCl3, 400 MHz): ö 8.26 (d,J=2.5 Hz, 1H), 7.88 (d,J2.5 Hz, 1H), 4.73 (d,J 5.8 Hz, 2H), 2.33 (t,J= 11.4 Hz, 1H); 13C NMR (CDCl3, 100 MHz): ö 147.12, 138.48, 138.39, 136.14, 132.06, 62.76. |
[ 65550-77-8 ]
2-Bromo-5-chloro-3-methylpyridine
Similarity: 0.87
[ 1227588-48-8 ]
2-Bromo-5-chloro-3-(chloromethyl)pyridine
Similarity: 0.81
[ 1211521-46-8 ]
2-Bromo-4-chloro-3-methylpyridine
Similarity: 0.72
[ 65550-77-8 ]
2-Bromo-5-chloro-3-methylpyridine
Similarity: 0.87
[ 1227588-48-8 ]
2-Bromo-5-chloro-3-(chloromethyl)pyridine
Similarity: 0.81
[ 22620-34-4 ]
(5-Chloro-3-pyridinyl)methanol
Similarity: 0.78
[ 1211521-46-8 ]
2-Bromo-4-chloro-3-methylpyridine
Similarity: 0.72
[ 22620-34-4 ]
(5-Chloro-3-pyridinyl)methanol
Similarity: 0.78
[ 55483-88-0 ]
(2,6-Dibromopyridin-3-yl)methanol
Similarity: 0.71
[ 1003711-43-0 ]
2-Bromo-5-hydroxy-3-methylpyridine
Similarity: 0.70
[ 65550-77-8 ]
2-Bromo-5-chloro-3-methylpyridine
Similarity: 0.87
[ 1227588-48-8 ]
2-Bromo-5-chloro-3-(chloromethyl)pyridine
Similarity: 0.81
[ 22620-34-4 ]
(5-Chloro-3-pyridinyl)methanol
Similarity: 0.78
[ 1211521-46-8 ]
2-Bromo-4-chloro-3-methylpyridine
Similarity: 0.72